Galina N. Salogub

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Case Report: Endovascular repair of thoracoabdominal aneurysm aorta and generalized mycobacterial infection (clinical case).

Case Report: Endovascular repair of thoracoabdominal aneurysm aorta and generalized mycobacterial infection (clinical case).

Journal: Frontiers in cardiovascular medicine

Published: May 05, 2025

Multicenter Single-Blind Randomized Controlled Trial of the Romiplostim Biosimilar.

Multicenter Single-Blind Randomized Controlled Trial of the Romiplostim Biosimilar.

Journal: EJHaem

Published: February 03, 2025

Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease

Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease

Journal: Terapevticheskii arkhiv

Published: January 23, 2025

Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.

Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.

Journal: International journal of molecular sciences

Published: April 15, 2023

Personalized treatment of malignant tumors during pregnancy.

Personalized treatment of malignant tumors during pregnancy.

Journal: Medicine

Published: July 01, 2022

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.

Journal: Trials

Published: November 25, 2021

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.

Journal: The Lancet. Haematology

Published: November 03, 2021

AL-amyloidosis with cardiac involvement. Diagnostic capabilities of non-invasive methods

AL-amyloidosis with cardiac involvement. Diagnostic capabilities of non-invasive methods

Journal: Terapevticheskii arkhiv

Published: April 15, 2021

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: May 26, 2020

Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.

Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.

Journal: Parkinsonism & related disorders

Published: May 14, 2020

Role of molecular-genetic abnormalities in pathogenesis and risk stratification of multiple myeloma.

Role of molecular-genetic abnormalities in pathogenesis and risk stratification of multiple myeloma.

Journal: Voprosy onkologii

Published: January 01, 2016

The synopsis of clinical cytometry: acute megakaryoblastic leukemia.

The synopsis of clinical cytometry: acute megakaryoblastic leukemia.

Journal: Klinicheskaia laboratornaia diagnostika

Published: January 01, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026